JP Morgan index shows global manufacturing contraction returns
Global manufacturing activity slipped back into contraction in July, as weak demand, lower exports, and cautious sentiment continued to weigh on production across major regions, according to the latest J.P.Morgan Global Manufacturing PMI.
XTEK’s HighCom receives $2.8M ballistic armour order from int’l customer
XTEK Limited’s HighCom Armor Solutions business has secured a $2.8 million order to supply its high-end ballistic body armour products to an undisclosed international customer.
EcoGraf to evaluate battery anode material manufacturing facility development in Vietnam
ASX-listed battery manufacturing company EcoGraf has teamed up with Vietnamese clean energy solutions provider VinES Energy to evaluate the development of a Vietnam-based battery anode material (BAM) facility.
UK car production slumps, while EV manufacturing surges in 2022
The latest result rounds off a volatile year for UK car production, with output down by 17.9 per cent in the month after growth in October and November, with most of the year’s volume loss occurring in the first half.
Amaero announces revised capital expenditure, EBITDA breakeven timeline
Amaero International, an ASX-listed company with manufacturing and corporate headquarters located in Tennessee, USA, has updated its financial guidance, revising key projections for capital expenditures and EBITDA breakeven timelines.
Aussie manufacturing sector records slower contraction in April – Judo Bank
Australia’s manufacturing sector experienced a slight contraction in April, but the pace of deterioration was notably slower than in previous months, according to the latest data from Judo Bank's PMI report.
BlueScope posts $805.7M NPAT for FY2024 amid industry challenges
BlueScope has reported a net profit after tax (NPAT) of $805.7 million for FY2024, marking a $203.5 million decline from FY2023.
Anteris awarded utility patent for novel transcatheter heart valve replacement
Australian biotechnology company Anteris Technologies announced that the US Patent and Trademark Office has issued another utility patent for its novel DurAVR transcatheter heart valve (THV).
CSR announces $100 million on-market repurchase plan
CSR is buying back up to $100 million in shares on-market, as the company positions itself to invest in both long-term growth strategy and...
New Zealand’s PMI contracts to 49.3 points in October
The New Zealand manufacturing industry’s market activity slipped into contraction territory in October.



























